Min Xue, Yuanyuan Guo, Qin Yan, Di Qin, Chun Lu. Preparation and application of polyclonal antibodies against KSHV v-cyclin[J]. The Journal of Biomedical Research, 2013, 27(5): 421-429. DOI: 10.7555/JBR.27.20120085
Citation:
Min Xue, Yuanyuan Guo, Qin Yan, Di Qin, Chun Lu. Preparation and application of polyclonal antibodies against KSHV v-cyclin[J]. The Journal of Biomedical Research, 2013, 27(5): 421-429. DOI: 10.7555/JBR.27.20120085
Min Xue, Yuanyuan Guo, Qin Yan, Di Qin, Chun Lu. Preparation and application of polyclonal antibodies against KSHV v-cyclin[J]. The Journal of Biomedical Research, 2013, 27(5): 421-429. DOI: 10.7555/JBR.27.20120085
Citation:
Min Xue, Yuanyuan Guo, Qin Yan, Di Qin, Chun Lu. Preparation and application of polyclonal antibodies against KSHV v-cyclin[J]. The Journal of Biomedical Research, 2013, 27(5): 421-429. DOI: 10.7555/JBR.27.20120085
We prepared rabbit polyclonal antibodies against Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded v-cyclin (ORF 72) and detected the natural viral protein using these polyclonal antibodies. Three antigenic polypep?tides of v-cyclin were designed and synthesized. A fragment of the v-cyclin gene was cloned into a eukaryotic expression vector pEF-MCS-Flag-IRES/Puro to construct a recombinant vector, pEF v-cyclin. Then, pEF v-cyclin was transfected into 293T and EA.hy926 cells to obtain v-cyclin-Flag fusion proteins. Six New Zealand white rabbits were immunized with KLH-conjugated peptides to generate polyclonal antibodies against v-cyclin. The polyclonal antibodies were then characterized by ELISA and Western blotting assays. Finally, the polyclonal anti?bodies against v-cyclin were used to detect natural viral protein expressed in BCBL-1, BC-3, and JSC-1 cells. The results showed that using the Flag antibody, v-cyclin-Flag fusion protein was detected in 293T and EA.hy926 cells transfected with pEF-v-cyclin. Furthermore, ELISA showed that the titer of the induced polyclonal rabbit anti-v-cyclin antibodies was higher than 1:8,000. In Western blotting assays, the antibodies reacted specifically with the v-cyclin-Flag fusion protein as well as the natural viral protein. The recombinant expression vector pEF-v-cyclin was constructed successfully, and the polyclonal antibodies prepared can be used for various biological tests in?cluding ELISA and Western blotting assays.
Nasimi Shad A, Moghbeli M. Integrins as the pivotal regulators of cisplatin response in tumor cells. Cell Commun Signal, 2024, 22(1): 265.
DOI:10.1186/s12964-024-01648-0
2.
Li J, Peng L, Chen Q, et al. Integrin β1 in Pancreatic Cancer: Expressions, Functions, and Clinical Implications. Cancers (Basel), 2022, 14(14): 3377.
DOI:10.3390/cancers14143377
3.
Dötzer K, Schlüter F, Koch FEV, et al. Integrin α2β1 Represents a Prognostic and Predictive Biomarker in Primary Ovarian Cancer. Biomedicines, 2021, 9(3): 289.
DOI:10.3390/biomedicines9030289
4.
Khine HEE, Ecoy GAU, Roytrakul S, et al. Chemosensitizing activity of peptide from Lentinus squarrosulus (Mont.) on cisplatin-induced apoptosis in human lung cancer cells. Sci Rep, 2021, 11(1): 4060.
DOI:10.1038/s41598-021-83606-1
5.
Moreira AM, Pereira J, Melo S, et al. The Extracellular Matrix: An Accomplice in Gastric Cancer Development and Progression. Cells, 2020, 9(2): 394.
DOI:10.3390/cells9020394
6.
Haeger A, Alexander S, Vullings M, et al. Collective cancer invasion forms an integrin-dependent radioresistant niche. J Exp Med, 2020, 217(1): e20181184.
DOI:10.1084/jem.20181184
7.
Yang XG, Zhu LC, Wang YJ, et al. Current Advance of Therapeutic Agents in Clinical Trials Potentially Targeting Tumor Plasticity. Front Oncol, 2019, 9: 887.
DOI:10.3389/fonc.2019.00887
8.
Manini I, Ruaro ME, Sgarra R, et al. Semaphorin-7A on Exosomes: A Promigratory Signal in the Glioma Microenvironment. Cancers (Basel), 2019, 11(6): 758.
DOI:10.3390/cancers11060758
9.
Raab-Westphal S, Marshall JF, Goodman SL. Integrins as Therapeutic Targets: Successes and Cancers. Cancers (Basel), 2017, 9(9): 110.
DOI:10.3390/cancers9090110